Component

Sustained alanine aminotransferase reduction

Sustained alanine aminotransferase reduction. Read linked claims for the population, experiment and limits.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. TONIC did not meet its primary sustained-ALT endpoint with vitamin E: 15/58 children (26%) responded versus 10/58 (17%) with placebo (P=0.26).

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    TONIC randomized double-blind trial; 173 children aged 8–17 with biopsy-confirmed NAFLD
    exposure
    RRR-alpha-tocopherol 400 IU twice daily for 96 weeks; E and placebo groups n=58 each.
    limitations
    Primary sustained-ALT endpoint and secondary histology must remain distinct. Not evidence for every child, every liver condition or long-term clinical outcome.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    The pediatric trial did not achieve its primary liver-enzyme outcome.
    primary_references
    [e-clin-tonic2011] Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. (2011). https://pubmed.ncbi.nlm.nih.gov/21521847/ DOI: 10.1001/jama.2011.520
    tissue_or_cell_type
    Liver enzymes and biopsy

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 1427–1438

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · TONIC randomized double-blind trial; 173 children aged 8–17 with biopsy-confirmed NAFLD · source_derived_draft · unverified_draft

    ### e-clin-tonic-alt TONIC did not meet its primary sustained-ALT endpoint with vitamin E: 15/58 children (26%) responded versus 10/58 (17%) with placebo (P=0.26). Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: The pediatric trial did not achieve its primary liver-enzyme outcome. organism: Homo sapiens tissue_or_cell_type: Liver enzymes and biopsy experimental_model: TONIC randomized double-blind trial; 173 children aged 8–17 with biopsy-confirmed NAFLD limitations: Primary sustained-ALT endpoint and secondary histology must remain distinct. Not evidence for every child, every liver condition or long-term clinical outcome. exposure: RRR-alpha-tocopherol 400 IU twice daily for 96 weeks; E and placebo groups n=58 each. cross_nutrient: false [e-clin-tonic2011] Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. (2011). https://pubmed.ncbi.nlm.nih.gov/21521847/ DOI: 10.1001/jama.2011.520
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards